Results 151 to 160 of about 4,673 (175)

The inhibitory effects of zinc oxide nanoparticles on clinical isolates of Microsporum canis in dogs and cats. [PDF]

Vet Med Sci
Khanipour Machiani M, Jamshidi S, Nikaein D, Khosravi A, Balal A.   +4 more
europepmc   +1 more source

FSH1 regulates the phenotype and pathogenicity of the pathogenic dermatophyte Microsporum canis. [PDF]

Int J Mol Med, 2019
Zhang F, Tan C, Xu Y, Yang G.
europepmc   +1 more source

Eruptive zoophilic dermatophytosis and the expanding role of molecular diagnostics. [PDF]

AME Case Rep
Gupta A, George A.
europepmc   +1 more source

Infection by Microsporum canis in Paediatric Patients: A Veterinary Perspective [PDF]

Veterinary Sciences, 2017
Microsporum canis is a dermatophyte fungus of which cats and dogs are recognized as the natural hosts. M. canis is also easily transmitted to humans, causing lesions to the glabrous skin (tinea corporis) and to the head (tinea capitis). The present study
Mario Pasquetti, Andrea Peano, Anna Rita Molinar Min   +2 more
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Comparative analysis of whole genomes and transcriptomes of Microsporum canis from invasive dermatophytosis and tinea capitis

Emerging Microbes and Infections, 2023
Ruojun Wang, Weixia Liu, Zhe Wan
exaly  

Efficacy of cyclic lipopeptides obtained from Bacillus subtilis to inhibit the growth of Microsporum canis isolated from cats

Heliyon, 2021
Paiboon Tunsagool, Sekkarin Ploypetch, Janthima Jaresitthikunchai   +2 more
exaly  

Genetic Characterization of Microsporum canis Clinical Isolates in the United States

Journal of Fungi (Basel, Switzerland), 2022
Alex Moskaluk, Roderick B Gagné, Christopher P Kozakiewicz   +2 more
exaly  

In vitro activities of 15 antifungal drugs against a large collection of clinical isolates of Microsporum canis

Mycoses, 2019
Jacques Guillot, Macit Ilkit, Samaneh Eidi   +2 more
exaly